C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2292795
The invention concerns an indirect genotypic method for diagnosing type 2 familial hemiplegic migraine in a person, characterised in that it consists in: isolating in said person's DNA the presence of a marker located on the 1a21-q23 chromosome in the locus limited by the D1S2343 and D1S2844 markers, said marker being related with the occurrence of familial hemiplegic migraine in his family.
La présente invention concerne une méthode de diagnostic génotypique indirect de la migraine hémiplégique familiale de type 2 chez un individu, caractérisée en ce que: on met en évidence dans l'ADN dudit individu la présence d'un marqueur situé sur le chromosome 1q21-q23 dans le locus limité par les marqueurs D1S2343 et D1S2844, ledit marqueur étant lié à la survenue de la migraine hémiplégique familiale au sein de sa famille.
Ducros Anne
Tournier Lasserve Elisabeth
Assistance Publique - Hopitaux de Paris
Institut National de La Sante Et de La Recherche Medicale
Robic
LandOfFree
Indirect genotypic method for diagnosing type 2 familial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indirect genotypic method for diagnosing type 2 familial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indirect genotypic method for diagnosing type 2 familial... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1507213